Skip to content
  • Home
  • Technologies
    • Overview
    • mRNA Reprogramming
    • Licensing
    • Technology Video Hub
  • GMP iPSCs
    • cGMP iPSCs Overview
    • Off-the-Shelf
    • Custom Development
    • Partnership for Autologous
  • Cell Therapy CDMO
    • CDMO Overview
    • cGMP iPSC Manufacturing
    • cGMP Single Cell Cloning
    • cGMP iPSC Quality Control
    • cGMP Consulting
    • cGMP Banking
    • Endotoxin Testing
  • Genome Editing
    • CRISPR Genome Editing
    • GMP Genome Editing
    • Gene Editing in iPSCs
  • News
Main Menu
Allele Biotech
cGMP iPSCs and Cell Therapy CDMO
Allele Biotech
  • Home
  • Technologies
    • Overview
    • mRNA Reprogramming
    • Licensing
    • Technology Video Hub
  • GMP iPSCs
    • cGMP iPSCs Overview
    • Off-the-Shelf
    • Custom Development
    • Partnership for Autologous
  • Cell Therapy CDMO
    • CDMO Overview
    • cGMP iPSC Manufacturing
    • cGMP Single Cell Cloning
    • cGMP iPSC Quality Control
    • cGMP Consulting
    • cGMP Banking
    • Endotoxin Testing
  • Genome Editing
    • CRISPR Genome Editing
    • GMP Genome Editing
    • Gene Editing in iPSCs
  • News
  • Home
  • Technologies
    • Overview
    • mRNA Reprogramming
    • Licensing
    • Technology Video Hub
  • GMP iPSCs
    • cGMP iPSCs Overview
    • Off-the-Shelf
    • Custom Development
    • Partnership for Autologous
  • Cell Therapy CDMO
    • CDMO Overview
    • cGMP iPSC Manufacturing
    • cGMP Single Cell Cloning
    • cGMP iPSC Quality Control
    • cGMP Consulting
    • cGMP Banking
    • Endotoxin Testing
  • Genome Editing
    • CRISPR Genome Editing
    • GMP Genome Editing
    • Gene Editing in iPSCs
  • News

Daily Archives: May 9, 2024

Allele and K Pharma enter into licensing agreement to develop regenerative medicine products

NewsBy Yuhui "Neil" NiMay 9, 2024

Allele Biotechnology Inc. (ALLELE) in San Diego, California, and K Pharma Inc. (K Pharma; TSE: 4896) in Tokyo, Japan, have entered into a licensing agreement to develop regenerative medicine products. K Pharma was founded as a spinoff from Keio University School of Medicine by co-founders Drs. Komei Fukushima, Masaya Nakamura and Hideyuki Okano, the coming…

©2025 by Allele Biotechnology and Pharmaceuticals Inc.

Go to Top